Autoimmune and ANA Testing: What You Need to Know
Antinuclear antibody (ANA) testing is one of the most frequently ordered laboratory tests when a healthcare provider is evaluating a person for a possible autoimmune condition. The test detects antibodies that bind to structures inside the cell nucleus, which can be a sign that the immune system is targeting the body's own tissues. However, ANA results must always be interpreted alongside symptoms, physical examination findings, and other laboratory tests, because a positive result does not by itself confirm an autoimmune disease and a negative result does not always rule one out.
Key takeaways
- ANA testing detects autoantibodies directed against components of the cell nucleus and is used as a screening tool in the evaluation of suspected systemic autoimmune disease.
- A positive ANA result is common in the general population, especially at low titers, and is not by itself a diagnosis of any specific condition.
- The pattern and titer of a positive ANA, along with the clinical picture, help guide whether additional, more specific autoantibody tests are needed.
- A negative ANA does not completely exclude autoimmune disease, since some conditions are ANA-negative or require different testing approaches.
What Is an Antinuclear Antibody (ANA) Test?
An antinuclear antibody (ANA) test is a blood test that measures antibodies directed against the nucleus of cells. Antibodies are proteins produced by the immune system to help defend the body against foreign substances such as bacteria and viruses. In some people, the immune system produces antibodies that recognize the body's own nuclear components, and these are called autoantibodies. The ANA test looks for this family of autoantibodies in the blood.
ANA testing is most often used as a screening test when a healthcare provider suspects a systemic autoimmune rheumatic disease, such as systemic lupus erythematosus, Sjogren's syndrome, scleroderma, or mixed connective tissue disease. Because the test is sensitive but not specific, it is generally ordered together with a careful history and physical examination rather than as a stand-alone diagnostic tool.
How ANA Testing Is Performed and Reported
ANA testing is usually performed on a blood sample collected from a vein in the arm. The most common laboratory method is indirect immunofluorescence using a cell substrate, which allows the laboratory to report both a titer and a staining pattern. The titer describes how much the sample can be diluted and still show detectable antibody, and the pattern describes where in the cell the antibodies appear to bind.
Results are typically reported as negative or positive, with a titer such as 1:40, 1:80, 1:160, or higher. Many laboratories consider 1:80 or 1:160 as the threshold for a positive result, though reporting conventions can vary. The pattern may include homogeneous, speckled, nucleolar, or other descriptions. Some laboratories also use enzyme immunoassay or multiplex methods as an initial screen, followed by immunofluorescence or specific antibody tests when indicated.
What a Positive or Negative ANA Result Means
A positive ANA result indicates that autoantibodies against nuclear components were detected, but it does not identify a specific disease. Low titers, such as 1:40 or 1:80, are relatively common in healthy people, and positivity becomes more frequent with increasing age. A positive result therefore needs to be interpreted in the context of the person's symptoms, such as joint pain, rash, fever, fatigue, or organ-specific findings.
If the ANA is positive and the clinical picture is suspicious, providers may order more specific autoantibody tests, such as anti-double-stranded DNA, anti-Smith, anti-Ro/SSA, anti-La/SSB, anti-Scl-70, or anti-centromere antibodies, to help narrow the differential diagnosis. A negative ANA makes certain conditions, particularly systemic lupus erythematosus, less likely but does not exclude all autoimmune diseases, because some are not associated with a positive ANA.
Limitations, False Results, and Appropriate Use
ANA testing has important limitations. It can produce false-positive results in people without autoimmune disease, and it can be positive in other conditions such as infections, certain cancers, and some medication exposures. It can also be negative in some people who truly have an autoimmune disease. Because of this, ANA testing should be ordered when there is a clinical reason to suspect an autoimmune condition, not as a general wellness screen.
The test is best used as part of a broader evaluation. Providers consider the person's history, physical examination, family history, and other laboratory findings, including complete blood count, comprehensive metabolic panel, urinalysis, and inflammatory markers. When a specific diagnosis is suspected, targeted autoantibody panels and, in some cases, referral to a rheumatologist may be appropriate.
Frequently Asked Questions
Can a positive ANA test alone diagnose lupus or another autoimmune disease?
No. A positive ANA test alone cannot diagnose lupus or any other autoimmune disease. It is a screening test that must be interpreted with symptoms, physical examination findings, and additional laboratory tests. Many people with a positive ANA do not have an autoimmune disease.
What does the ANA titer mean?
The titer indicates how much the blood sample can be diluted and still show detectable antinuclear antibodies. Higher titers are more strongly associated with autoimmune disease, but titer alone does not confirm a diagnosis. Low titers can occur in healthy individuals.
Should I get an ANA test if I have no symptoms?
ANA testing is generally not recommended for people without symptoms or clinical signs suggesting an autoimmune condition, because a positive result in a low-risk person is often not meaningful and can lead to unnecessary worry and further testing. Testing should be guided by a healthcare provider.
What other tests might be ordered after a positive ANA?
Depending on symptoms and the suspected condition, a provider may order more specific autoantibody tests such as anti-double-stranded DNA, anti-Smith, anti-Ro/SSA, anti-La/SSB, anti-Scl-70, or anti-centromere antibodies, along with general tests such as a complete blood count, metabolic panel, urinalysis, and inflammatory markers.
Sources
Ready to get tested? Examine the included markers, read the collection notes, and reserve the panel with the LabTestingCenter partner today.
Order ANA Blood Test | Antinuclear Antibodies TestingReviewed by the LabTestingCenter Editorial Team
Each laboratory panel is reviewed by the LabTestingCenter editorial desk against authoritative reference data.